Veille Pharma

CSD Promotion Audits Reveal Trend to "Digital" in 2012; Global Investment in Online Channels Up 40% Over 2011 While Sales Forces See Major Cuts in Established Markets

Markets can expect a wave of medicines to hit the market, said Eli Lilly's CEO.

De nombreuses études sur la e-santé voient le jour chaque année afin d’en percer tous les mystères. La plupart du temps, pour ne pas dire toujours, elles sont commanditées par des entreprises, agen...

Multiple myeloma remains an incurable neoplasm of plasma cells that affects more than 20,000 people annually in the United States. There has been a veritable revolution in this disease during the past decade, with dramatic improvements in our understanding of its pathogenesis, the development of several novel agents, and a concomitant doubling in overall survival. Because multiple myeloma is a complex and wide-ranging disorder, its management must be guided by disease- and patient-related factors; emerging as one of the most influential factors is risk stratification, primarily based on cytogenetic features. A risk-adapted approach provides optimal therapy to patients, ensuring intense therapy for aggressive disease and minimizing toxic effects, providing sufficient but less intense therapy for low-risk disease. This consensus statement reflects recommendations from more than 20 Mayo Clinic myeloma physicians, providing a practical approach for newly diagnosed patients with myeloma who are not enrolled in a clinical trial.

The mobile health application market is headed for explosive growth, according to a new report by Research and Markets, which has projected the market will swell 61 percent by 2017, reaching $26 billion. 

Digital marketing is transforming the landscape of the healthcare industry and enabling consumers to interact with data in ways that are more engaging and personal than in years past.

Plus de 200 produits se sont avérés indisponibles ces trois dernières années en France. Des pénuries liées à un...

A rep walks into an HCP’s office. He’s relaxed and confident. After all, their last interaction went without a hitch. In fact, the weeks following the visit saw increased prescription rates of his brand.

Pharma companies have been reluctant to make a move onto social, unsure of the return on investment (ROI) offered by the channel and worried about the regulatory environment.

L’offre des applis mobiles santé ne cesse de croître, et dans un précédent article je mentionnais quelques réalisations permettant de s’y retrouver parmi ces listes pléthoriques affichées sur les s...

Myeloma cells have unique protein biosynthesis gear and in this aspect differ from all other types of cancer cells.

L’ingénieur du génome annonce le lancement commercial de lignées cellulaires permettant d'identifier des candidats...

Sanofi donne le coup d'envoi de son étude Télésage qui devrait valider l'intérêt médical et l'impact médico-économique de Diabeo®, une solution permettant aux diabétiques de calculer leurs doses d'insulines en temps réel et d'ajuster leur traitement.